fluorodeoxyglucose f18 has been researched along with Vaginal Neoplasms in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (42.86) | 29.6817 |
2010's | 9 (42.86) | 24.3611 |
2020's | 3 (14.29) | 2.80 |
Authors | Studies |
---|---|
Duarte, LH; Gouveia, P; Nunes, S; Petiz, A; Sá Pinto, A; Teixeira, R; Violante, L | 1 |
Albuquerque, KS; Bernardo, GCO; D'Ippolito, G; de Araújo, EM; Gomes, NBN; Lewin, F; Libânio, BB; Pedroso, MHNI; Racy, DJ; Souza E Silva, TX; Torres, US; Zoghbi, KK | 1 |
Kuang, A; Pan, L; Shen, G; Wang, R | 1 |
Bhosale, PR; Devine, C; Faria, S; Javadi, S; Korivi, BR; Viswanathan, C | 1 |
Beriwal, S; Comerci, JT; Courtney-Brooks, M; Edwards, RP; Gebhardt, BJ; Glaser, SM; Houser, CJ; Kelley, JL; Kim, H; Olawaiye, AB; Sukumvanich, P; Vargo, JA | 1 |
Chen, X; Fu, Z; Li, Q; Yang, X | 1 |
Fan, Q; Liu, H; Su, M; Wang, R | 1 |
Adams, R; Debernardo, R; Dowlati, A; Faulhaber, P; Fusco, N; Kunos, CA; Radivoyevitch, T; Redline, R; Resnick, K; Waggoner, S; Zanotti, K | 1 |
Abu-Rustum, NR; Benz, M; Hricak, H; Lyons, G; Robertson, NL; Sala, E; Sonoda, Y; Sosa, RE; Vargas, HA | 1 |
Atmaca Saglik, B; Basoglu, T; Sahin, M; Ucak Semirgin, S; Yapici, O | 1 |
Bentivegna, E; Duvillard, P; Gouy, S; Haie-Meder, C; Leboulleux, S; Lumbroso, J; Morice, P; Uzan, C | 1 |
Kahr, HS; Lund, B; Mejlgaard, E | 1 |
Bourguet, P | 1 |
Carp, L; De Beeck, BO; Tjalma, WA | 1 |
Bridji, B; Oudoux, A; Resche, I; Rousseau, C; Rousseau, T | 1 |
Fulham, MJ; Mohamed, A; Thambugala, GM | 1 |
Dehdashti, F; Gibb, RK; Grigsby, PW; Lamoreaux, WT; Mutch, DG; Powell, MA; Rader, JS; Siegel, BA; Zoberi, I | 1 |
Dehdashti, F; Gao, F; Gibb, RK; Grigsby, PW; Herzog, TJ; Huettner, PC; Mutch, DG; Powell, MA; Rader, JS; Siegel, BA; Wright, JD | 1 |
Grahek, D; Talbot, JN | 1 |
Akhurst, T; Alektiar, K; Barakat, RR; Chi, DS; Husain, A; Larson, S | 1 |
3 review(s) available for fluorodeoxyglucose f18 and Vaginal Neoplasms
Article | Year |
---|---|
Vaginal cancer: Why should we care? Anatomy, staging and in-depth imaging-based review of vaginal malignancies focusing on MRI and PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Vaginal Neoplasms | 2022 |
FDG-PET Assessment of Other Gynecologic Cancers.
Topics: Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiographic Image Enhancement; Sensitivity and Specificity; Uterine Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 2018 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in gynecological neoplasms].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms; Vaginal Neoplasms | 2003 |
1 trial(s) available for fluorodeoxyglucose f18 and Vaginal Neoplasms
Article | Year |
---|---|
Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemoradiotherapy; Cisplatin; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Pyridines; Thiosemicarbazones; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vaginal Neoplasms | 2013 |
17 other study(ies) available for fluorodeoxyglucose f18 and Vaginal Neoplasms
Article | Year |
---|---|
18F-FDG PET/CT in Patients with Vulvar and Vaginal Cancer: A Preliminary Study of 20 Cases.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Vaginal Neoplasms | 2022 |
Malignant Extrarenal Rhabdoid Tumor of the Vagina on FDG PET/CT.
Topics: Child; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Rhabdoid Tumor; Vaginal Neoplasms | 2021 |
Image-based multichannel vaginal cylinder brachytherapy for the definitive treatment of gynecologic malignancies in the vagina.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Treatment Outcome; Vaginal Neoplasms | 2018 |
Diagnosis of Primary Clear Cell Carcinoma of the Vagina by 18F-FDG PET/CT.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Vaginal Neoplasms | 2019 |
Isolated Vaginal Recurrence of Early-Stage Rectal Cancer Detected by 18F-FDG PET/CT.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms; Vaginal Neoplasms | 2019 |
The impact of FDG-PET/CT in the management of patients with vulvar and vaginal cancer.
Topics: Carcinoma; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Vaginal Neoplasms; Vulvar Neoplasms | 2016 |
Diagnostic value of additional 18F-FDG PET/CT imaging using a vaginal catheter in patients with paravaginal malignant lesions.
Topics: Adult; Aged; Aged, 80 and over; Catheters; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Vagina; Vaginal Neoplasms | 2016 |
[The accuracy of FDG-PET/CT in early-stage cervical and vaginal cancers].
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Uterine Cervical Neoplasms; Vaginal Neoplasms; Young Adult | 2011 |
[Primary malignant melanoma of the vagina].
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Vaginal Neoplasms | 2013 |
False-positive positron emission tomographic scan and computed tomography for recurrent vaginal cancer: pitfalls of modern imaging techniques.
Topics: Adult; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed; Vaginal Neoplasms | 2004 |
[2003 update of recommendations for clinical practice: standards, options and recommendations for the use of FDG-PET in the management of gynaecological and breast cancers].
Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Metastasis; Neoplasm, Residual; Ovarian Neoplasms; Tomography, Emission-Computed; Uterine Neoplasms; Vaginal Neoplasms | 2004 |
Interest of F-18 fluorodeoxyglucose positron emission tomography in the evaluation of vaginal malignant melanoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Vaginal Neoplasms | 2004 |
Vaginal melanoma mimicking bladder FDG activity in a patient with chronic renal failure.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney Failure, Chronic; Melanoma; Radionuclide Imaging; Radiopharmaceuticals; Urinary Bladder Diseases; Vaginal Neoplasms | 2005 |
FDG-PET evaluation of vaginal carcinoma.
Topics: Carcinoma; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Vaginal Neoplasms | 2005 |
Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography.
Topics: Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lymph Nodes; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms; Vaginal Neoplasms | 2005 |
[Update of 'standards, options and recommendations' for FDG-PET in breast and gynaecological cancers].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; France; Genital Neoplasms, Female; Humans; Neoplasm Metastasis; Ovarian Neoplasms; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms; Vaginal Neoplasms | 2006 |
A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pelvic Exenteration; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 2007 |